Brief: Journey Medical Corporation Announces Successful Completion of Pre-NDA Meeting with the FDA for DFD-29 to Treat Rosacea
06/12/2023 13:14
Dec 6 (Reuters) - Journey Medical Corp DERM.O :
* JOURNEY MEDICAL CORPORATION ANNOUNCES SUCCESSFUL
COMPLETION OF
PRE-NDA MEETING WITH THE FDA FOR DFD-29 TO TREAT ROSACEA
* JOURNEY MEDICAL - FDA AGREED THAT PROPOSED DATA PACKAGE
SUFFICIENT TO SUPPORT NDA SUBMISSION, CONTINUES TO ANTICIPATE
WILL OCCUR AROUND 2023 YEAR-END
Source text for Eikon: ID:nGNX1lk4hM
Further company coverage: DERM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Journey Medical
See all newsJourney Medical Corp expected to post a loss of 1 cent a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce
U.S. STOCKS ON THE MOVE-Cerebras, Madison Square Garden Sports
U.S. STOCKS ON THE MOVE-Five Below, Salesforce, IBM, Akamai Technologies